BOSTON / Apr 23, 2024 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the first quarter 2024 before market open on Tuesday, April 30, 2024. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast... Read More

Fostering Relationships with the NATO Support and Procurement Agency and the DrugDetect EU project, 908 Devices’ MX908 Deployed Across Europe for Trace Chemical Detection and Identification BOSTON / Mar 12, 2024 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption of the MX908 for trace... Read More

Fourth quarter 2023 revenue increased 23% compared to prior year, driven by handheld revenue increasing 57% BOSTON / Mar 05, 2024 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter and full year ended December 31, 2023. "We made solid progress in 2023 towards our objectives. We have... Read More

BOSTON & SOUTH SAN FRANCISCO, Calif. / Feb 29, 2024 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and Cellares , the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and commercial-scale cell therapy manufacturing, announce a development collaboration to integrate in-line monitoring of... Read More

BOSTON / Feb 22, 2024 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the following investor conferences. Cowen 44 th Annual Healthcare Conference, Boston, MA Fireside chat on Wednesday, March 6 th at 9:50 a.m. Eastern Time / 6:50 a.m. Pacific Time KeyBanc Life Sciences & MedTech Forum... Read More

BOSTON / Feb 20, 2024 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the fourth quarter and full year 2023 before market open on Tuesday, March 5, 2024. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio... Read More

Broadens the reach of trace detection and identification at the point of need to enhance safety BOSTON / Nov 14, 2023 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced that it has expanded access to its leading trace detection technology in its handheld MX908 device through the addition of a weatherproof, digital... Read More

BOSTON / Nov 07, 2023 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter ended September 30, 2023. "We are pleased with the step-up in our revenues from the second quarter and the positive growth trend over the past nine months, despite the challenging environment in the life... Read More

Automation combined with on-line monitoring during the cell expansion step can bring cell therapy manufacturing efficiencies and enable increased patient accessibility and safety BOSTON & LAKEWOOD, Colo. / Nov 06, 2023 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and medical technology company Terumo Blood and Cell... Read More

BOSTON / Oct 31, 2023 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the following investor conferences. 53 rd Annual Baird Industrial Conference In-person presentation only on Wednesday, November 8 th at 10:35 a.m. Pacific Time / 1:35 a.m. Eastern Time Stifel Healthcare Conference 2023... Read More

BOSTON / Oct 24, 2023 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces today that it has been awarded a total of $10.4 million in purchase orders from the United States Air Force and Air National Guard Fire & Emergency Services Program for its MX908 handheld mass spectrometry device with Aero module. Approximately a... Read More

BOSTON / Oct 24, 2023 / Business Wire / 908 Devices Inc. , (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the third quarter 2023 before market open on Tuesday, November 7, 2023. Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time. Live audio of the... Read More

MAVERICK is a Raman-based PAT solution that requires no complex modeling BOSTON / Sep 18, 2023 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the launch of MAVERICK , an optical in-line analyzer that provides real-time monitoring and control of glucose, lactate, and total biomass in mammalian cell cultures, in... Read More

BOSTON / Sep 15, 2023 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the upcoming Gilmartin Group Emerging Growth Company Showcase. 908 Devices’ management is scheduled to present on Thursday, September 21 at 9:00 a.m. Eastern Time. Interested parties may access a live and archived webcast... Read More

Revenue increases 9% compared to prior year, driven by handheld revenue growth of 27% BOSTON / Aug 08, 2023 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter ended June 30, 2023. “We delivered solid results in the second quarter driven by robust demand for our handheld devices and... Read More

BOSTON / Jul 25, 2023 / Business Wire / 908 Devices Inc. , (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the second quarter 2023 before market open on Tuesday, August 8, 2023. Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time. Live audio of the... Read More

Key oral presentation highlights the company’s prototype microfluidic chips for multi-omics workflows BOSTON / May 30, 2023 / Business Wire / 908 Devices Inc (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, is showcasing its ZipChip CE-MS device for rapid characterization of critical product quality attributes for biologics, oligonucleotides, RNAs, and AAVs, with... Read More

BOSTON / May 23, 2023 / Business Wire / 908 Devices Inc. , (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the upcoming William Blair 43 rd Annual Growth Stock Conference. 908 Devices’ management is scheduled to present on Wednesday, June 7 at 1:20 p.m. Central Time / 2:20 p.m. Eastern Time. Interested parties may access a live and... Read More

Q1 2023 revenue increases 14% compared to prior year with recurring revenue growing 67% BOSTON / May 09, 2023 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter ended March 31, 2023. “I am pleased to see the strong recurring value that our technology brings to our customers by... Read More

New tool is built on the JMP statistical software package BOSTON / May 04, 2023 / Business Wire / 908 Devices Inc . , (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced the release of a data analysis tool that provides a quick and effortless way to analyze and visualize the wealth of data generated by the REBEL at-line cell culture media analyzer. The tool... Read More

BOSTON / Apr 26, 2023 / Business Wire / 908 Devices Inc . , (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced that National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company, has adopted REBEL at-line media analyzers in their process development to inform and optimize cell culture feed strategies and media design. REBEL provides... Read More

BOSTON / Apr 25, 2023 / Business Wire / 908 Devices Inc. , (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the first quarter 2023 before market open on Tuesday, May 9, 2023. Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time. Live audio of the webcast... Read More

BOSTON / Mar 07, 2023 / Business Wire / 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter and full year ended December 31, 2022. “While we are pleased with the progress made against our long-term objectives in 2022, as anticipated, we experienced protracted sales cycles and more conservative capital... Read More

BOSTON / Feb 21, 2023 / Business Wire / 908 Devices Inc. , (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the upcoming Cowen 43 rd Annual Healthcare Conference in Boston, MA. 908 Devices’ management is scheduled to host a fireside chat on Wednesday, March 8 at 9:50 a.m. Eastern Time. Interested parties may access a live and archived... Read More

MAVEN offers real-time monitoring without bioreactor volume loss, accelerating process development and optimizing biologics, cell therapy and gene therapy manufacturing 908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced the launch of MAVEN , a device for on-line monitoring and control of glucose and lactate in cell culture and fermentation... Read More